The iconic rise of Viagra has firmly established as a example of pharmaceutical success, however its position within the broader market now triggers questions about future returns . Generic versions are undercutting patent protection , causing worries that supporting companies heavily reliant to Viagra's once-dominant standing could be a dangerous